FORTE BIOSCIENCES, INC. Royalty Expense
FORTE BIOSCIENCES, INC. (FBRX) reported Royalty Expense of $25.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2023-03-31
- FORTE BIOSCIENCES, INC. royalty expense for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. royalty expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. royalty expense for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. royalty expense for the quarter ending 2022-03-31 was $25.00K.
- FORTE BIOSCIENCES, INC. royalty expense for fiscal 2022 was $25.00K, a 75.00% decline from fiscal 2021.
- FORTE BIOSCIENCES, INC. royalty expense for fiscal 2021 was $100.00K.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $25.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $25.00K 10-Q · filed 2022-11-14 | $50.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | $25.00K 10-Q · filed 2022-08-15 | $50.00K derived: sum of 3 quarters · filed 2023-03-31 | $75.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $25.00K derived: 10-K 12 month − 3 quarters · filed 2023-03-31 | $50.00K derived: sum of 2 quarters · filed 2023-03-31 | $75.00K derived: sum of 3 quarters · filed 2023-03-31 | $100.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $50.00K derived: sum of 2 quarters · filed 2023-03-31 | $75.00K derived: sum of 3 quarters · filed 2023-03-31 | $100.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $25.00K 10-Q · filed 2022-11-14 | $50.00K derived: sum of 2 quarters · filed 2022-11-14 | $75.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $25.00K 10-Q · filed 2022-08-15 | $50.00K 10-Q · filed 2022-08-15 |